VR Adviser, LLC
- SEC CIK
- 0001615982
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 31
- −6 vs. Q1 2025
- Portfolio value
- $1.33B
- +$159.2M (+13.5%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TENXTenax Therapeutics, Inc. | COM NEW | 98,564 | $567.7K | <0.1% | −109,769−52.7% | Reduced | History |
| CASIFCASI Pharmaceuticals, Inc. | ORD SHS | 987,259 | $1.16M | 0.1% | 00.0% | Unchanged | History |
| ARTVArtiva Biotherapeutics, Inc. | COM | 1,609,569 | $2.43M | 0.2% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 4,631,216 | $4.86M | 0.4% | −391,950−7.8% | Reduced | History |
| SRZNSurrozen, Inc. | COM NEW | 632,931 | $5.66M | 0.4% | 00.0% | Unchanged | History |
| SEPNSepterna, Inc. | COM | 540,453 | $5.71M | 0.4% | +540,453 | New | History |
| FRNMFreenome, Inc. | CL A ORD SHS | 750,000 | $7.96M | 0.6% | 00.0% | Unchanged | History |
| ABVXAbivax S.A. | SPONSORED ADS | 1,345,780 | $10.3M | 0.8% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,379,965 | $10.4M | 0.8% | 00.0% | Unchanged | History |
| ATXSAstria Therapeutics, Inc. | COM | 2,457,348 | $13.2M | 1.0% | 00.0% | Unchanged | History |
| ENGNenGene Therapeutics Inc. | COM | 5,046,414 | $18.4M | 1.4% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 1,000,000 | $18.6M | 1.4% | −744,373−42.7% | Reduced | History |
| SVRASavara Inc | COM | 8,884,263 | $20.3M | 1.5% | +5,626,624+172.7% | Added | History |
| DYNDyne Therapeutics, Inc. | COM | 2,173,913 | $20.7M | 1.6% | 00.0% | Unchanged | History |
| CBIOCrescent Biopharma, Inc. | COM | 1,387,864 | $22.4M | 1.7% | +1,387,864 | New | History |
| ERASErasca, Inc. | COM | 17,857,083 | $22.7M | 1.7% | +1,640,867+10.1% | Added | History |
| UPBUpstream Bio, Inc. | COM | 2,295,319 | $25.2M | 1.9% | 00.0% | Unchanged | History |
| CDTXCidara Therapeutics, Inc. | COM NEW | 639,088 | $31.1M | 2.3% | −412,430−39.2% | Reduced | History |
| CTMXCytomX Therapeutics, Inc. | COM | 13,969,882 | $31.7M | 2.4% | +13,969,882 | New | History |
| JBIOJade Biosciences, Inc. | COM NEW | 3,220,364 | $32.2M | 2.4% | +3,220,364 | New | History |
| COGTCogent Biosciences, Inc. | COM | 4,755,411 | $34.1M | 2.6% | −929,000−16.3% | Reduced | History |
| PHVSPharvaris N.V. | COM | 2,047,620 | $36.0M | 2.7% | −1,065,100−34.2% | Reduced | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 2,685,448 | $40.2M | 3.0% | 00.0% | Unchanged | History |
| ORKAOruka Therapeutics, Inc. | COM | 4,148,428 | $46.5M | 3.5% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 3,882,709 | $54.3M | 4.1% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 6,596,885 | $67.0M | 5.0% | +3,414,358+107.3% | Added | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 6,728,985 | $76.1M | 5.7% | +25,000+0.4% | Added | History |
| ELVNEnliven Therapeutics, Inc. | COM | 4,026,331 | $80.8M | 6.1% | 00.0% | Unchanged | History |
| MTSRMetsera, Inc. | COM | 3,750,662 | $106.7M | 8.0% | 00.0% | Unchanged | History |
| OCULOcular Therapeutix, Inc | COM | 12,762,462 | $118.4M | 8.9% | 00.0% | Unchanged | History |
| APGEApogee Therapeutics, Inc. | COM | 8,493,321 | $368.9M | 27.6% | 00.0% | Unchanged | History |
Sold out since Q1 2025 (10)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 989,985 | $37.5M | 3.2% | History |
| SLDBSolid Biosciences Inc. | COM NEW | 2,481,400 | $9.18M | 0.8% | History |
| TRVITrevi Therapeutics, Inc. | COM | 615,506 | $3.87M | 0.3% | History |
| APLTApplied Therapeutics, Inc. | COM | 5,567,709 | $2.72M | 0.2% | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 677,600 | $2.19M | 0.2% | History |
| MRSNMersana Therapeutics, Inc. | COM | 3,574,325 | $1.23M | 0.1% | History |
| IPSCCentury Therapeutics, Inc. | COM | 2,498,069 | $1.19M | 0.1% | History |
| TNYATenaya Therapeutics, Inc. | COM | 1,555,556 | $886.8K | 0.1% | History |
| CBIOCrescent Biopharma, Inc. | COM | 3,000,000 | $630.0K | 0.1% | History |
| TILInstil Bio, Inc. | COM NEW | 33,177 | $576.0K | <0.1% | History |